Asian Pacific Journal of Cancer Prevention

  • 제17권4호
  • /
  • Pages.2341-2342
  • /
  • 2016
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Does Indian Myelodysplastic Syndrome have a Biology Different from that in the West ?

  • Chaubey, Rekha (Department of Hematology, All India Institute of Medical Sciences) ;
  • Sazawal, Sudha (Department of Hematology, All India Institute of Medical Sciences) ;
  • Mahapatra, Manoranjan (Department of Hematology, All India Institute of Medical Sciences) ;
  • Chhikara, Sunita (Department of Hematology, All India Institute of Medical Sciences) ;
  • Saxena, Renu (Department of Hematology, All India Institute of Medical Sciences)
  • 발행 : 2016.06.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Chaubey R, Sazawal S, Mahapatra M, et al (2015).Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients. Int J Lab Hematol, 37, 265-71. https://doi.org/10.1111/ijlh.12283
  2. Chen B, Zhao WL, Jin J, et al.(2005). Clinical and cytogenetic features of 508 patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia, 19, 767-75. https://doi.org/10.1038/sj.leu.2403688
  3. Goldberg SL, Chen E, Corral M, et al (2010). Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol, 28, 2847-52. https://doi.org/10.1200/JCO.2009.25.2395
  4. Lee JJ, Kim HJ, Chung IJ, et al (1999). Comparisons of prognostic scoring systems for myelodysplastic syndromes: a Korean multicenter study. Leuk Res, 23, 425-32. https://doi.org/10.1016/S0145-2126(99)00032-6
  5. Ma X, Does M, Raza A, et al (2007). Myelodysplastic syndromes: incidence and survival in the United States. Cancer, 109, 1536-42. https://doi.org/10.1002/cncr.22570
  6. Matsuda A, Germing U, Jinnai I, et al (2005). Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood, 106, 2633- 40. https://doi.org/10.1182/blood-2005-01-0040
  7. Neukirchen J, Schoonen WM, Strupp C, et al (2011). Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS-registry. Leuk Res, 35, 1591-96. https://doi.org/10.1016/j.leukres.2011.06.001
  8. Sekeres MA (2010). The epidemiology of myelodysplastic syndromes. Hematol Oncol Clin North Am, 24, 287-94. https://doi.org/10.1016/j.hoc.2010.02.011
  9. Magalhaes SMM, Heredia FF, Fernandes LCM, et al (2013). Beyond race-related disparities - is myelodysplastic syndrome the same everywhere? Leuk Lymphoma, 54, 1564-66. https://doi.org/10.3109/10428194.2012.749404
  10. Sole F, Luño E, Sanzo C, et al (2005) Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica, 90, 1168-78.